BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960 | +37.1% | 25,442 | +48.1% | 0.08% | +31.6% |
| Q2 2023 | $700 | +0.4% | 17,182 | 0.0% | 0.06% | 0.0% |
| Q1 2023 | $697 | -20.4% | 17,182 | 0.0% | 0.06% | -25.0% |
| Q4 2022 | $876 | -99.9% | 17,182 | 0.0% | 0.08% | -10.6% |
| Q3 2022 | $925,000 | -16.2% | 17,182 | 0.0% | 0.08% | -13.3% |
| Q2 2022 | $1,104,000 | -17.1% | 17,182 | 0.0% | 0.10% | -3.9% |
| Q1 2022 | $1,332,000 | -9.7% | 17,182 | 0.0% | 0.10% | -7.3% |
| Q4 2021 | $1,475,000 | +6.7% | 17,182 | 0.0% | 0.11% | -2.7% |
| Q3 2021 | $1,382,000 | -0.1% | 17,182 | 0.0% | 0.11% | -0.9% |
| Q2 2021 | $1,383,000 | -4.6% | 17,182 | 0.0% | 0.11% | -13.6% |
| Q1 2021 | $1,449,000 | +5.1% | 17,182 | 0.0% | 0.13% | -1.5% |
| Q4 2020 | $1,379,000 | +8.8% | 17,182 | +9.0% | 0.13% | -3.6% |
| Q3 2020 | $1,267,000 | -24.7% | 15,757 | -15.7% | 0.14% | -29.8% |
| Q2 2020 | $1,682,000 | +41.0% | 18,687 | +27.1% | 0.20% | +17.9% |
| Q1 2020 | $1,193,000 | -2.9% | 14,697 | 0.0% | 0.17% | -8.2% |
| Q4 2019 | $1,229,000 | +134.1% | 14,697 | +144.9% | 0.18% | +115.3% |
| Q3 2019 | $525,000 | +6.7% | 6,002 | 0.0% | 0.08% | +4.9% |
| Q2 2019 | $492,000 | +0.8% | 6,002 | 0.0% | 0.08% | -4.7% |
| Q1 2019 | $488,000 | -44.8% | 6,002 | -55.3% | 0.08% | -58.5% |
| Q4 2018 | $884,000 | -14.6% | 13,432 | 0.0% | 0.20% | -0.5% |
| Q3 2018 | $1,035,000 | +4.3% | 13,432 | 0.0% | 0.21% | -1.9% |
| Q2 2018 | $992,000 | +13.5% | 13,432 | 0.0% | 0.21% | +8.8% |
| Q1 2018 | $874,000 | +0.7% | 13,432 | 0.0% | 0.19% | +1.6% |
| Q4 2017 | $868,000 | -17.7% | 13,432 | -20.1% | 0.19% | -21.2% |
| Q3 2017 | $1,055,000 | +3.6% | 16,812 | 0.0% | 0.24% | -3.6% |
| Q2 2017 | $1,018,000 | +16.7% | 16,812 | 0.0% | 0.25% | +9.2% |
| Q1 2017 | $872,000 | +17.0% | 16,812 | 0.0% | 0.23% | +7.0% |
| Q4 2016 | $745,000 | +90.5% | 16,812 | +104.7% | 0.21% | +84.5% |
| Q3 2016 | $391,000 | -29.9% | 8,211 | -33.4% | 0.12% | -32.2% |
| Q2 2016 | $558,000 | -32.4% | 12,331 | -38.6% | 0.17% | -33.2% |
| Q1 2016 | $825,000 | +7.7% | 20,077 | 0.0% | 0.26% | +3.2% |
| Q4 2015 | $766,000 | +60.9% | 20,077 | +38.5% | 0.25% | +51.2% |
| Q3 2015 | $476,000 | -39.0% | 14,491 | +29.8% | 0.16% | -34.9% |
| Q2 2015 | $780,000 | +1.0% | 11,161 | 0.0% | 0.25% | -2.7% |
| Q1 2015 | $772,000 | -5.6% | 11,161 | 0.0% | 0.26% | -7.5% |
| Q4 2014 | $818,000 | -21.7% | 11,161 | -19.9% | 0.28% | -26.7% |
| Q3 2014 | $1,045,000 | +3.7% | 13,941 | 0.0% | 0.38% | +2.1% |
| Q2 2014 | $1,008,000 | -1.8% | 13,941 | 0.0% | 0.37% | -7.7% |
| Q1 2014 | $1,026,000 | +5.8% | 13,941 | 0.0% | 0.40% | +3.6% |
| Q4 2013 | $970,000 | +25.2% | 13,941 | +18.1% | 0.39% | +17.8% |
| Q3 2013 | $775,000 | -5.1% | 11,801 | 0.0% | 0.33% | -10.3% |
| Q2 2013 | $817,000 | – | 11,801 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |